Post-Launch Checklist: Five Key Factors For Sustained Post‑launch Success

Getting a therapy to market is a milestone, but it rarely marks the end of meaningful commercial work. Patient needs shift, payer landscapes evolve, and distribution demands compound as products mature. The question isn't whether your post-launch strategy will need to adjust; it's whether your commercialization partner is equipped to adjust with it.

This checklist identifies five areas where the right partner separates adequate support from genuinely sustained performance: provider and patient education delivered by qualified clinical professionals, structured programs for removing access barriers including formulary expansion and hub services, global distribution infrastructure capable of resolving real-time logistics challenges, uptake and engagement analytics tied directly to KPI-driven adjustments, and ongoing strategic analysis that accounts for how market conditions shift as a product matures.

Each factor compounds the others. A gap in any one area creates downstream friction, whether that's lower adherence, stalled access, or missed commercial targets. Use this checklist to assess where your current partnership stands and identify where stronger capabilities could close the gap.